|
Market Closed -
Bombay S.E.
05:02:26 2026-11-04 EST
|
5-day change | 1st Jan Change | ||
| 9.380 INR | +7.20% |
|
+5.63% | -34.41% |
| 10-01 | Gennex Laboratories Limited Announces Board Changes | CI |
| 08-14 | Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Gennex Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 494.6 | 952.6 | 1,004 | 3,594 | 2,741 | 1,732 |
| Change | - | 92.58% | 5.42% | 257.85% | -23.73% | -36.8% |
| Enterprise Value (EV) 1 | 566.5 | 978.9 | 1,036 | 3,181 | 2,466 | 2,152 |
| Change | - | 72.81% | 5.79% | 207.16% | -22.47% | -12.74% |
| P/E | 12.3x | 24.3x | 16.7x | 26x | 15.4x | 8.26x |
| PBR | 1.25x | 2.17x | 1.23x | 2.11x | 1.47x | 0.78x |
| PEG | - | -8.74x | 1.94x | 0.3x | 0.5x | 0.8x |
| Capitalization / Revenue | 0.82x | 1.56x | 1.53x | 4.14x | 1.99x | 1x |
| EV / Revenue | 0.94x | 1.6x | 1.58x | 3.67x | 1.79x | 1.25x |
| EV / EBITDA | 8.03x | 17.9x | 20.8x | 18.3x | 14.5x | 9.55x |
| EV / EBIT | 9.18x | 20.9x | 25.6x | 21.2x | 16.4x | 10.8x |
| EV / FCF | -20.6x | 32.8x | -5.89x | -6.22x | -9.86x | -1.65x |
| FCF Yield | -4.86% | 3.05% | -17% | -16.1% | -10.1% | -60.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.319 | 0.3101 | 0.3369 | 0.608 | 0.783 | 0.8635 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 600.4 | 612.1 | 656 | 867.1 | 1,379 | 1,727 |
| EBITDA 1 | 70.53 | 54.76 | 49.7 | 173.9 | 170.4 | 225.4 |
| EBIT 1 | 61.72 | 46.88 | 40.51 | 150.2 | 150.5 | 198.9 |
| Net income 1 | 40.38 | 39.23 | 49.21 | 131.8 | 181.2 | 209.8 |
| Net Debt 1 | 71.83 | 26.33 | 31.28 | -412.9 | -274.8 | 419.5 |
| Reference price 2 | 3.910 | 7.530 | 5.610 | 15.800 | 12.050 | 7.130 |
| Nbr of stocks (in thousands) | 126,503 | 126,503 | 179,010 | 227,448 | 227,448 | 242,948 |
| Announcement Date | 9/8/21 | 9/9/22 | 9/9/23 | 9/7/24 | 9/8/25 | 9/8/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 22.44M | |
| 41.24x | 13.94x | 30.97x | 0.48% | 1,255B | |
| 38.96x | 6.55x | 18.42x | 2.01% | 641B | |
| 36.79x | 8.37x | 17.26x | 2.42% | 505B | |
| 21.08x | 5.12x | 12.75x | 2.56% | 381B | |
| 95.75x | 5.88x | 25.02x | 2.35% | 357B | |
| 22.88x | 5.88x | 14.19x | 2.73% | 303B | |
| 24.26x | 4.85x | 13.68x | 1.8% | 286B | |
| 29.25x | 7.46x | 13.36x | 2.19% | 249B | |
| -40.09x | 7.32x | 45.96x | 1.97% | 208B | |
| Average | 30.01x | 7.26x | 21.29x | 2.06% | 418.52B | |
| Weighted average by Cap. | 35.93x | 8.73x | 22.53x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- GENNEX6 Stock
- Valuation Gennex Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
